Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion
- PMID: 23709688
- DOI: 10.1189/jlb.0113018
Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion
Abstract
Recent studies indicate that murine Tregs highly express the ENTDP1, as well as the 5'-NT and thereby, suppress Teff function by extracellular adenosine production. Furthermore, CD73 seems to play a role as costimulatory molecule for T cell differentiation. In this study, we analyzed the expression of CD73 on peripheral and lymph nodal Teffs and Tregs in a cohort of 95 HIV patients at different stages of disease, including LTNP and ECs. In contrast to murine Tregs, CD73 was only expressed on a small minority (∼10%) of peripheral Tregs. In contrast, we see high expression of CD73 on peripheral CD8(+) T cells. In HIV infection, CD73 is markedly reduced on all Teffs and Tregs, regardless of the memory subtype. On CD8(+) T cells, a positive correlation between CD73 expression and CD4 counts (P=0.0003) was detected. CD73 expression on CD8(+) T cells negatively correlated with HLA-DR (<0.0001) and PD1 (P=0.0457) expression. The lower CD73 expression on CD8(+) T cells was partially reversible after initiation of ART (P=0.0016). Functionally, we observed that CD8(+)CD73(+) T cells produce more IL-2 upon HIV-specific and unspecific stimulation than their CD73(-) counterparts and show a higher proliferative capacity. These data indicate that down-regulation of CD73 on CD8(+) T cells correlates with immune activation and leads to functional deficits in HIV infection.
Keywords: 5′-ectonucleotidase; CD39; adenosine; elite controller; regulatory T cell.
Comment in
-
Editorial: CD73 deficiency and immune dysregulation in HIV infection: cause or effect?J Leukoc Biol. 2013 Oct;94(4):545-7. doi: 10.1189/jlb.0513245. J Leukoc Biol. 2013. PMID: 24082048 Free PMC article.
Similar articles
-
Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.J Infect Dis. 2012 May 15;205(10):1501-9. doi: 10.1093/infdis/jis230. Epub 2012 Mar 28. J Infect Dis. 2012. PMID: 22457273
-
Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression.J Leukoc Biol. 2017 May;101(5):1263-1271. doi: 10.1189/jlb.5A0816-346R. Epub 2017 Feb 13. J Leukoc Biol. 2017. PMID: 28193736
-
HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.J Infect Dis. 2014 May 1;209(9):1321-30. doi: 10.1093/infdis/jit643. Epub 2013 Dec 19. J Infect Dis. 2014. PMID: 24357632
-
CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.FEBS Lett. 2015 Nov 14;589(22):3454-60. doi: 10.1016/j.febslet.2015.07.027. Epub 2015 Jul 29. FEBS Lett. 2015. PMID: 26226423 Review.
-
CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth.J Biomed Biotechnol. 2012;2012:485156. doi: 10.1155/2012/485156. Epub 2012 Oct 16. J Biomed Biotechnol. 2012. PMID: 23125525 Free PMC article. Review.
Cited by
-
CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression.Nat Commun. 2021 Oct 8;12(1):5911. doi: 10.1038/s41467-021-26134-w. Nat Commun. 2021. PMID: 34625545 Free PMC article.
-
High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4+ T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19.Viruses. 2022 Jun 10;14(6):1265. doi: 10.3390/v14061265. Viruses. 2022. PMID: 35746736 Free PMC article.
-
Immune Activation and Inflammation in People With Human Immunodeficiency Virus: Challenging Targets.J Infect Dis. 2020 Apr 27;221(10):1567-1570. doi: 10.1093/infdis/jiz351. J Infect Dis. 2020. PMID: 31282534 Free PMC article. No abstract available.
-
A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation.J Infect Dis. 2020 Apr 27;221(10):1598-1606. doi: 10.1093/infdis/jiz344. J Infect Dis. 2020. PMID: 31282542 Free PMC article. Clinical Trial.
-
Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).Mol Biol Cell. 2014 Dec 15;25(25):4024-33. doi: 10.1091/mbc.E14-06-1167. Epub 2014 Oct 8. Mol Biol Cell. 2014. PMID: 25298403 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials